Geetanjali Sharma

Title: Geetanjali Sharma: Innovator in Molecular Biology

Introduction

Geetanjali Sharma is a prominent inventor based in Albuquerque, NM (US). She has made significant contributions to the field of molecular biology and pharmacology, particularly in the treatment of obesity, diabetes, cardiovascular, and kidney diseases. With a total of 3 patents to her name, her work is paving the way for innovative therapeutic approaches.

Latest Patents

One of Geetanjali's latest patents focuses on a method for treating obesity, diabetes, cardiovascular, and kidney diseases by regulating GPR30/GPER activity. This invention provides methods for using compounds that modulate the effects of GPR30/GPER, particularly agonists for treating obesity and diabetes. Additionally, it addresses disease states resulting from excessive formation of reactive oxygen species, utilizing antagonists to counteract these effects. The compounds may function as both agonists and antagonists of the disclosed estrogen receptor, while also modulating the expression and upregulation of nox and nox-associated reactive oxygen species (ROS).

Career Highlights

Geetanjali Sharma is affiliated with The University of New Mexico, where she continues her research and development in molecular biology. Her innovative work has garnered attention in the scientific community, contributing to advancements in therapeutic methods.

Collaborations

Geetanjali has collaborated with notable colleagues, including Eric R Prossnitz and Matthias Barton. Their combined expertise enhances the research and development of effective treatments in their field.

Conclusion

Geetanjali Sharma is a trailblazer in the realm of molecular biology, with her patents reflecting her commitment to addressing critical health issues. Her innovative approaches are set to make a lasting impact on the treatment of various diseases.